Found: 6
Select item for more details and to access through your institution.
DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 917, doi. 10.3390/cancers11070917
- By:
- Publication type:
- Article
Patient Reported Outcome Measures in multiple myeloma: real-time rePorTing to improve care (My-PROMPT) - a pilot randomised controlled trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e340, doi. 10.1016/j.clml.2019.09.561
- By:
- Publication type:
- Article
Strengthening the myeloma nursing network in Australia and New Zealand (ANZ): Leading best supportive care.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e345, doi. 10.1016/j.clml.2019.09.570
- By:
- Publication type:
- Article
DNA-repair gene mutations are prevalent in circulating tumour DNA from advanced multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e79, doi. 10.1016/j.clml.2019.09.126
- By:
- Publication type:
- Article
Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Patient‐reported outcome measures in multiple myeloma: Real‐time reporting to improve care (My‐PROMPT) ‐ a pilot randomized controlled trial.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. E178, doi. 10.1002/ajh.25815
- By:
- Publication type:
- Article